Am J Perinatol 2015; 32(01): 009-014
DOI: 10.1055/s-0034-1371703
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Inotrope Use among Extremely Preterm Infants in Canadian Neonatal Intensive Care Units: Variation and Outcomes

Jonathan Wong
1   Department of Pediatrics, Kingston General Hospital, Kingston, Ontario, Canada
,
Prakesh S. Shah
2   Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada
,
Eugene W. Yoon
3   MiCare Research Centre, Mount Sinai Hospital, Toronto, Ontario, Canada
,
Wendy Yee
4   Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada
,
Shoo Lee
2   Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada
,
Kimberly Dow
1   Department of Pediatrics, Kingston General Hospital, Kingston, Ontario, Canada
› Author Affiliations
Further Information

Publication History

22 September 2013

29 January 2014

Publication Date:
04 April 2014 (online)

Abstract

Objective To compare neonatal outcomes between infants who received inotropes and those who did not, and identify variation in inotrope use.

Study Design Retrospective review of data from neonates < 29 weeks gestation collected by the Canadian Neonatal Network during 2003 to 2010. After controlling for confounders and maternal/infant characteristics, rates of mortality and major morbidity were compared between those who received inotropes on days 1 and 3 of admission and those who did not. Rate of inotrope use was compared between sites.

Results Inotropes were administered to 772 (10%) of the 7,913 neonates. Infants who received inotropes had significantly higher illness severity, surfactant use, and need for mechanical ventilation. Inotrope use was also associated with significantly higher rates of mortality (adjusted odds ratio [AOR] = 2.05 [1.64, 2.57]), retinopathy of prematurity (AOR = 2.04 [1.54, 2.71]), intraventricular hemorrhage (AOR = 1.59 [1.29, 1.93]), bronchopulmonary dysplasia (AOR = 1.38 [1.11, 1.72]), and necrotizing enterocolitis (AOR = 2.06 [1.59, 2.67]). Rates of inotrope use varied significantly between participating sites (0–36%; AOR = 0 [0, 0.1]–7.7 [2.9, 21]).

Conclusion Risk of mortality and major morbidities were significantly higher in neonates who received inotropes. Inotrope use varied significantly among Canadian neonatal intensive care units.

Site Investigators of the Canadian Neonatal Network

Prakesh S Shah (Director, Canadian Neonatal Network, Toronto, Ontario); Wayne Andrews (Janeway Childrenʼs Health and Rehabilitation Centre, St Johnʼs, Newfoundland and Labrador); Keith Barrington (Sainte Justine Hospital, Montreal, Quebec); Wendy Yee (Foothills Medical Centre, Calgary, Alberta); Barbara Bullied (Everett Chalmers Hospital, Fredericton, New Brunswick); Rody Canning (Moncton Hospital, Moncton, New Brunswick); Ruben Alvaro (St. Boniface General Hospital, Winnipeg, Manitoba); Kimberly Dow (Kingston General Hospital, Kingston, Ontario); Michael Dunn (Sunnybrook Health Sciences Centre, Toronto, Ontario); Adele Harrison (Victoria General Hospital, Victoria, British Columbia); Kyong-Soon Lee (The Hospital for Sick Children, Toronto, Ontario); Zarin Kalapesi (Regina General Hospital, Regina, Saskatchewan); Lajos Kovacs (Jewish General Hospital, Montreal, Quebec); Orlando da Silva (St. Josephʼs Health Centre; London, Ontario); Douglas D. McMillan (IWK Health Centre, Halifax, Nova Scotia); Prakesh Shah (Mount Sinai Hospital, Toronto, Ontario); Cecil Ojah (St. John Regional Hospital, St. John, New Brunswick); Abraham Peliowski/Khalid Aziz (Royal Alexandra Hospital, Edmonton, Alberta); Bruno Piedboeuf (Centre hospitalier universitaire de Québec, Sainte Foy, Quebec); Patricia Riley (Montreal Children's Hospital, Montreal, Quebec); Daniel Faucher (Royal Victoria Hospital, Montreal, Quebec); Nicole Rouvinez-Bouali (Children's Hospital of Eastern Ontario, Ottawa, Ontario); Koravangattu Sankaran (Royal University Hospital, Saskatoon, Saskatchewan); Mary Seshia (Health Sciences Centre, Winnipeg, Manitoba); Sandesh Shivananda (Hamilton Health Sciences Centre, Hamilton, Ontario); Zenon Cieslak (Royal Columbian Hospital, New Westminster, British Columbia); Anne Synnes (Children's and Women's Health Centre of British Columbia, Vancouver, British Columbia); Herve Walti (Centre Hospitalier Universitaire de Sherbrooke, Fleurimont, Quebec), and Shoo K. Lee, (Chairman, Canadian Neonatal Network, Toronto, Ontario).


 
  • References

  • 1 Al-Aweel I, Pursley DM, Rubin LP, Shah B, Weisberger S, Richardson DK. Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs. J Perinatol 2001; 21 (5) 272-278
  • 2 Dempsey EM, Barrington KJ. Treating hypotension in the preterm infant: when and with what: a critical and systematic review. J Perinatol 2007; 27 (8) 469-478
  • 3 Batton B, Li L, Newman NS , et al; Eunice Kennedy Shriver National Institute of Child Health & Human Development Neonatal Research Network. Use of antihypotensive therapies in extremely preterm infants. Pediatrics 2013; 131 (6) e1865-e1873
  • 4 Osborn D, Paradisis M, Evans N. The effect of inotropes on morbidity and mortality in preterm infants with low systemic or organ blood flow. Cochrane Database Syst Rev 2007; 24 (1) CD005090
  • 5 Osborn D, Evans N, Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr 2002; 140 (2) 183-191
  • 6 Golder V, Hepponstall M, Yiallourou SR, Odoi A, Horne RS. Autonomic cardiovascular control in hypotensive critically ill preterm infants is impaired during the first days of life. Early Hum Dev 2013; 89 (6) 419-423
  • 7 Valverde E, Pellicer A, Madero R, Elorza D, Quero J, Cabañas F. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. Pediatrics 2006; 117 (6) e1213-e1222
  • 8 Logan JW, O'Shea TM, Allred EN , et al; ELGAN Study Investigators. Early postnatal hypotension is not associated with indicators of white matter damage or cerebral palsy in extremely low gestational age newborns. J Perinatol 2011; 31 (8) 524-534
  • 9 Logan JW, O'Shea TM, Allred EN , et al; ELGAN Study Investigators. Early postnatal hypotension and developmental delay at 24 months of age among extremely low gestational age newborns. Arch Dis Child Fetal Neonatal Ed 2011; 96 (5) F321-F328
  • 10 Garner RS, Burchfield DJ. Treatment of presumed hypotension in very low birthweight neonates: effects on regional cerebral oxygenation. Arch Dis Child Fetal Neonatal Ed 2013; 98 (2) F117-F121
  • 11 Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores. J Pediatr 2001; 138 (1) 92-100
  • 12 International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123 (7) 991-999
  • 13 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92 (4) 529-534
  • 14 Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82 (4) 527-532
  • 15 Bell MJ, Ternberg JL, Feigin RD , et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187 (1) 1-7
  • 16 Canadian Neonatal Network. Abstractor's manual. Toronto: Canadian Neonatal Network; 2010
  • 17 Osborn DA, Evans N, Kluckow M, Bowen JR, Rieger I. Low superior vena cava flow and effect of inotropes on neurodevelopment to 3 years in preterm infants. Pediatrics 2007; 120 (2) 372-380
  • 18 Synnes AR, Chien LY, Peliowski A, Baboolal R, Lee SK ; Canadian NICU Network. Variations in intraventricular hemorrhage incidence rates among Canadian neonatal intensive care units. J Pediatr 2001; 138 (4) 525-531
  • 19 Short BL, Van Meurs K, Evans JR ; Cardiology Group. Summary proceedings from the cardiology group on cardiovascular instability in preterm infants. Pediatrics 2006; 117 (3 Pt 2) S34-S39
  • 20 Seri I, Evans J. Controversies in the diagnosis and management of hypotension in the newborn infant. Curr Opin Pediatr 2001; 13 (2) 116-123
  • 21 Van Marter LJ, Leviton A, Allred EN, Pagano M, Kuban KC. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr 1990; 116 (6) 942-949
  • 22 Goldberg RN, Chung D, Goldman SL, Bancalari E. The association of rapid volume expansion and intraventricular hemorrhage in the preterm infant. J Pediatr 1980; 96 (6) 1060-1063
  • 23 Ewer AK, Tyler W, Francis A, Drinkall D, Gardosi JO. Excessive volume expansion and neonatal death in preterm infants born at 27-28 weeks gestation. Paediatr Perinat Epidemiol 2003; 17 (2) 180-186
  • 24 Batton BJ, Li L, Newman NS , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Feasibility study of early blood pressure management in extremely preterm infants. J Pediatr 2012; 161 (1) 65-69 , e1
  • 25 Lee SK, Zupancic JA, Pendray M , et al; Canadian Neonatal Network. Transport risk index of physiologic stability: a practical system for assessing infant transport care. J Pediatr 2001; 139 (2) 220-226